Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: A case report

Clinical and Experimental Rheumatology

Volumn 25, Issue 5, 2007, Pages 758-759

  Guignard, Sandra ^a,c   Dien, Georges ^b   Dougados, Maxime ^a  

^a Rheumatology B Department ^*  (France)

^b Hyeres Hospital   (France)

^c CENTRE HOSPITALIER DE MEAUX   (France)

Author keywords

Acute respiratory distress syndrome; Adult onset Still's disease; Anakinra; ARDS; Severe systemic inflammatory response syndrome; Shock; SIRS

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; CORTICOSTEROID; HYDROXYCHLOROQUINE; HYPERTENSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STEROID;

ADULT; ADULT ONSET STILL DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG MEGADOSE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; REMISSION; SYMPTOM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; ANTIRHEUMATIC AGENTS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT; STILL'S DISEASE, ADULT-ONSET; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 37349007708     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. COFFERNILS M, SOUPART A, PRADIER O, FEREMANS W, NEVE P, DECAUX G: Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. J Rheumatol 1992; 19: 1425-7.
2. KUMAKURA S, ISHIKURA H, MUNEMASA S, ADACHI T, MURAKAWA Y, KOBAYASHI S: Adult onset Still's disease associated hemophagocytosis. J Rheumatol 1997; 24: 1645-8.
3. FERREIROS J: REGINATO AJ, SCHUMACHER HR JR, BAKER DG, O'CONNOR CR, FERREIROS J: Adult onseE Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 1987; 17: 39-57.
4. A WOUTERS JM, VAN DE PUTTE LB: Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 1986; 61: 1055-65.
5. POUCHOT J, SAMPALIS JS, BEAUDET F et al.: Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine 1991; 70: 118-136.
6. HIROHATA S, KAMOSHITA H, TAKETANI T, MAEDA S: Adult Still's disease complicated with adult respiratory distress. Arch Intern Med 1986; 146: 2409-10.
7. IGLESIAS J, SATHIRAJU S, MARIK PE: Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: Clinical response with high-dose pulse methylprednisolone therapy. Chest 1999; 115: 1738-40.
8. RANGEL-FRAUSTO MS, PITTET D, COSTIGAN M, HWANG T, DAVIS CS, WENZEL RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273: 117-23.
9. MUCKART DJ, BHAGWANJEE S: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25: 1789-95.
10. RAVELLI A, CARIA MC, BURATTI S, MALATTIA C, TEMPORINI F, MARTINI A: Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2001; 28: 865-7.
11. DINARELLO CA: Blocking IL-1 in systemic inflammation. J Exp Med 2005; 201: 1355-9.
12. VENCOVSKY J, JAROSOVA K, RUZICKOVA S et al.: Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 2387-91.
13. VERBSKY JW, WHITE AJ: Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J Rheumatol 2004; 31: 2071-5.
14. VASQUES GODINHO FM, PARREIRA SANTOS MJ, CANAS DA SILVA J: Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005; 64: 647-8.
15. FITZGERALD AA, LECLERCQ SA, YAN A, HOMIK JE, DINARELLO CA: Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005; 52: 1794-803.
16. LANGER HE, MISSLER-KARGER B. KINERET: Efficacy and safety in daily clinical practice: An interim analysis of the Kineret response assessment initiative (kreative) protocol. Int J Clin Pharmacol Res 2003; 23: 119-28.
17. FLEISCHMANN RM: Addressing the safety of anakinra in patients with rheumatoid arthritis. Rheumatology 2003; 42 (Suppl. 2): Ii29-35.
18. BENUCCI M, LI GF, DEL ROSSO A, MANFREDI M: Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult onset Still's disease: the first case report. Clin Exp Rheum 2005; 23: 733.